Form 8-K - Current report:
SEC Accession No. 0001193125-23-222604
Filing Date
2023-08-28
Accepted
2023-08-28 16:10:54
Documents
12
Period of Report
2023-08-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d528651d8k.htm   iXBRL 8-K 21292
  Complete submission text file 0001193125-23-222604.txt   142253

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lnth-20230822.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20230822_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20230822_pre.xml EX-101.PRE 11264
6 EXTRACTED XBRL INSTANCE DOCUMENT d528651d8k_htm.xml XML 3355
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 231215661
SIC: 2835 In Vitro & In Vivo Diagnostic Substances